The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...

Previous research has demonstrated that activin receptor-like kinase 7 (ALK7) signaling suppresses lipolysis, resulting in increased adipocyte size and lipid content. Additionally, predicted loss of ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced presentation of preclinical data supporting the advancement of two first-in-class clini ...

Figure 1: Neuroprotection by bFGF is associated with increased expression of activin βA mRNA. Recently, a different type of interaction between bFGF and the TGF-β superfamily was reported from ...

在市场强劲势头推动下，iBio Inc.股价飙升至52周新高，触及5.03美元。对于这家专注于开发和生产植物制药的生物技术公司来说，这一价格水平代表着重要里程碑。根据 InvestingPro 数据显示，该股票的贝塔系数为-3.29，往往与市场趋势相反。过去一年，iBio股价实现了221.37%的显著回报，尤其在过去六个月中表现强劲，涨幅达95.83%。虽然收入增长达650%， ...

(NASDAQ: ARWR) today announced preclinical results on ARO-ALK7, the company’s investigational RNA interference (RNAi) therapeutic targeting Activin receptor-like kinase 7 (ALK7) being developed ...

Arrowhead (ARWR) announced preclinical results on ARO-ALK7, the company’s investigational RNA interference therapeutic targeting Activin receptor-like kinase 7 being developed as a potential ...

Unfortunately, CCBs only seem helpful for a small percentage of people with PAH. Winrevair (sotatercept) is the first activin signaling inhibitor therapy approved to treat PAH. By regulating PAH cell ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

One of the categories of drugs currently under investigation for the treatment of muscle loss includes drugs that inhibit the activation of the activin receptor or the signaling pathway activated ...

Discovered a novel antibody targeting activin E in collaboration with AstralBio, leveraging iBio’s Machine-Learning Antibody Engine to overcome significant technical challenges, demonstrating ...

Health Canada’s acceptance of the submission follows that of the Ministry of Health, Labour and Welfare (WHLW) in Japan and approval by the US Food and Drug Administration (FDA) and the European ...